An overview of investigational new drugs for treating ankylosing spondylitis.

about

A Possible Role of Intestinal Microbiota in the Pathogenesis of Ankylosing Spondylitis Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis: A meta-analysis.Developments with experimental and investigational drugs for axial spondyloarthritis.

P2860

Q28069331-06A0D3CE-056A-41A2-8F80-DED3DD3BCEAA Q33833623-A6A057FC-B1BB-46C7-A170-346B3B0CEE27 Q38676714-866A1070-855D-40E8-8830-95754A13B84C

P2860

An overview of investigational new drugs for treating ankylosing spondylitis.

Item

http://www.wikidata.org/entity/Q38631462

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

An overview of investigational new drugs for treating ankylosing spondylitis.

@en

type

Item

label

An overview of investigational new drugs for treating ankylosing spondylitis.

@en

prefLabel

An overview of investigational new drugs for treating ankylosing spondylitis.

@en

P1476

An overview of investigational new drugs for treating ankylosing spondylitis.

@en

P2860

TNF-alpha inhibitors for ankylosing spondylitis

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

The intestinal microbiome in spondyloarthritis

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.

Rituximab treatment for spondyloarthritis. A nationwide series: data from the AIR registry of the French Society of Rheumatology.

Selective JAK inhibitors in development for rheumatoid arthritis.

Cost effectiveness of therapeutic interventions in ankylosing spondylitis: a critical and systematic review.

The role of the gut and microbes in the pathogenesis of spondyloarthritis.

Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)

Predictors of response to TNF antagonists in patients with ankylosing spondylitis and psoriatic arthritis: systematic review and meta-analysis.

P304

95-104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.2016.1116519

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Daniel Wendling

P577

2015-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26561014

http://www.w3.org/2001/XMLSchema#string

An overview of investigational new drugs for treating ankylosing spondylitis.

about

P2860

P2860

An overview of investigational new drugs for treating ankylosing spondylitis.

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698